Pfeil Keith W's Form 4/A amendment
AmendedGlobus Medical Inc (GMED) · filed Feb 6, 2023
- Accession no.
- 0001209191-23-007310
- Filed
- Feb 6, 2023
- Trade date
- Aug 19, 2021
- Filing delay
- 536 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Aug 23, 2021
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $63.4K. It was filed 536 days after the trade.
This amendment replaces 0001209191-21-052968 (filed Aug 23, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pfeil Keith WCIK 0001752014 | Officer (SVP, Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2021 | Class A Common Stock | MOption exerciseAcquired | +833 | $49.65F1 | +$41,358.45 | 833 | Direct | |
| Aug 19, 2021 | Class A Common Stock | SSaleDisposed | −833 | $76.13 | −$63,416.29 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2021 | Class A Common Stock | MOption exerciseDisposed | −833 | $0.00 | $0 | 20,000 | Direct | |
| Aug 19, 2021 | Class A Common Stock | MOption exerciseDisposed | 0 | $0.00 | $0 | 24,167 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on August 19, 2021 at an exercise price of $53.27 when in fact such options were exercised at a price of $49.65.
Referenced by the price of 1 transaction in Table I.
- F2
This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
- F3
These options were granted on September 3, 2019 and are fully vested.
- F4
The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a transaction that occurred on August 19, 2021 as exercising a total of 833 options granted on January 22, 2020 when in fact such options were granted on September 3, 2019. As a result of this administrative error, the number of derivative securities beneficially owned by the reporting person following the corrected transaction reflects an increase by 833 in the number of options granted in 2020 and a decrease by 833 in the number of options granted in 2019.
- F5
These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.